Featured Research

from universities, journals, and other organizations

Molecular Architects Create New Cancer Preventives

Date:
August 23, 2000
Source:
Johns Hopkins University
Summary:
Researchers at Johns Hopkins have developed a modified form of vitamin D and determined that it helps delay the onset and reduce the number of skin cancers in lab mice. Unlike vitamin D, though, the new compound does not cause calcium to seep from the bones.

EMBARGOED FOR RELEASE AT 12:45 P.M. EDT ON TUESDAY, AUG. 22

Researchers at The Johns Hopkins University have developed a modified form of vitamin D and determined that it helps delay the onset and reduce the number of skin cancers in lab mice. Unlike vitamin D, though, the new compound does not cause calcium to seep from the bones.

If not for the calcium loss problem, large doses of vitamin D could be used to reduce the odds of developing cancer in patients whose medical history, genetic heritage, or environmental exposures put them at increased risk. Depending on the results of further tests in animals and potential tests in humans, the new compound and others to follow it may provide an important alternative approach to reducing cancer risk for such patients.

Gary Posner, Scowe Professor of Chemistry in Johns Hopkins' Krieger School of Arts and Sciences and one of the new compound's creators, will describe work to design and test the compounds at a meeting of the American Chemical Society in Washington, D.C., this week.

In the July/August issue of "Carcinogenesis," Posner and Thomas Kensler, professor at the Johns Hopkins School of Public Health, published results of tests in mice of four modified forms of vitamin D, called deltanoids or vitamin D analogs. The deltanoids were applied to the skin of mice also treated with a carcinogen.

All four deltanoids diminished the number of skin tumors without any significant effects on calcium loss or weight gain, which is usually adversely affected by vitamin D. The most effective preventive compound was a doubly modified "hybrid" compound that contained fluorine.

The new deltanoids are, for the most part, identical to vitamin D, which is normally generated in the skin during exposure to sunlight. In several areas, though, Posner and his students have given the compounds' molecular structures several small "tweaks."

"We call our work molecular architecture, because at the submicroscopic level we are altering the structures of known compounds or designing new compounds from scratch," explains Posner.

Those alterations can include adding components to, taking things away from, and re-orienting parts of the molecule.

"It's still a science and an art combined," Posner explains. "It's not yet possible for anyone to go from a new chemical structure and to predict in advance the biological properties of that new structure."

This inability of molecular architects to predict exactly the results of their design changes can sometimes force them to rely on their intuitive sense of which change will produce the desired result. But the design process is also rational, Posner emphasizes, because it is based to the greatest extent possible on principles established through prior experimentation. Earlier research in the deltanoids included many efforts by pharmaceutical companies to improve vitamin D.

"What we did was to take some of the best structural changes that large pharmaceutical companies have made public," Posner says, "and incorporated those changes with a structural change that we discovered here 10 years ago in a different portion of the molecule."

Posner's group found that if they added a methylene group, composed of one extra carbon atom and two hydrogen atoms, to an area of the vitamin D molecule known as the A ring, the molecule caused much less calcium loss.

Based on the research of another lab, Posner's group also added two fluorine atoms to the molecule at an ideal point to reduce the body's ability to break down and metabolize the vitamin D analogs. This not only reduces the levels of potentially harmful metabolites produced by the analogs, it also keeps the analogs active in the body longer.

The changes are all small compared to the size of the vitamin D molecule, which has a total of 27 carbon atoms. But they make a significant difference in its effects.

"You might think you'd have to change large portions of the molecule to change its biological effects, but it's well-known that you can do that by changing small portions of the molecule," Posner says.

Further animal tests of the analog on different types of tumors are planned in Kensler's lab. If the new tests and tests in humans prove successful, doctors might one day be able to consider treating patients at high risk for cancer with the compound, probably applying it as a topical gel.

Meanwhile, Posner's lab is already at work on yet another generation of improved deltanoids.

"There's a lot of trial and error," he says. "My research group has, over the years, made about 100 different vitamin D analogs. And the winners are probably limited to 10. If you consider the more general issue in the pharmaceutical industry, though, going from the bench to a drug, typically it's one in many thousands of compounds. And that gives you a feeling for just how far rational design can or can't come."

This research was funded in part by grants from The National Cancer Institute of the National Institutes of Health.

###

For recorded quotes from Posner, go to http://www.jhu.edu/news_info/news/home00/aug00/vitamind.html


Story Source:

The above story is based on materials provided by Johns Hopkins University. Note: Materials may be edited for content and length.


Cite This Page:

Johns Hopkins University. "Molecular Architects Create New Cancer Preventives." ScienceDaily. ScienceDaily, 23 August 2000. <www.sciencedaily.com/releases/2000/08/000817143445.htm>.
Johns Hopkins University. (2000, August 23). Molecular Architects Create New Cancer Preventives. ScienceDaily. Retrieved October 1, 2014 from www.sciencedaily.com/releases/2000/08/000817143445.htm
Johns Hopkins University. "Molecular Architects Create New Cancer Preventives." ScienceDaily. www.sciencedaily.com/releases/2000/08/000817143445.htm (accessed October 1, 2014).

Share This



More Health & Medicine News

Wednesday, October 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

Ebola Cases Keep Coming for Monrovia's Island Hospital

Ebola Cases Keep Coming for Monrovia's Island Hospital

AFP (Oct. 1, 2014) A look inside Monrovia's Island Hospital, a key treatment centre in the fight against Ebola in Liberia's capital city. Duration: 00:34 Video provided by AFP
Powered by NewsLook.com
Ebola Puts Stress on Liberian Health Workers

Ebola Puts Stress on Liberian Health Workers

AP (Oct. 1, 2014) The Ebola outbreak is putting stress on first responders in Liberia. Ambulance drivers say they are struggling with chronic shortages of safety equipment and patients who don't want to go to the hospital. (Oct. 1) Video provided by AP
Powered by NewsLook.com
Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Doctors Reassure Public Ebola Patient Won't Cause Outbreak

Newsy (Sep. 30, 2014) After the announcement that the first U.S. patient had been diagnosed with Ebola, doctors were quick to say a U.S. outbreak is highly unlikely. Video provided by Newsy
Powered by NewsLook.com
TX Hospital Confirms Patient Admitted With Ebola

TX Hospital Confirms Patient Admitted With Ebola

AP (Sep. 30, 2014) Medical officials from Texas Health Presbyterian Hospital confirm they are treating a patient with the Ebola virus, the first case found in the US. (Sept. 30 Video provided by AP
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:

Strange & Offbeat Stories


Health & Medicine

Mind & Brain

Living & Well

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins